{"schema_version":"secwatch.filing_event.v1","accession":"0001387131-22-002576","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2022-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.418578+00:00","generated_at":"2026-06-27T03:58:31.278620+00:00","sec_items":["5.02","5.03","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aspira Women's Health appoints Sandford as CEO, Palmieri as Executive Chair","bullets":["Nicole Sandford appointed President and CEO effective March 1, 2022; base salary $500,000, one-year term.","Valerie Palmieri transitions to Executive Chair effective March 1; base salary $450,000, one-year term.","Celeste Fralick, Ph.D., appointed to Board effective Feb 23, 2022; will serve on Audit Committee.","Bylaws amended to require lead director selection if Board chair is not an independent director."],"urls":{"canonical":"https://secwatch.observer/filing/0001387131-22-002576","json":"https://secwatch.observer/filing/0001387131-22-002576.json","markdown":"https://secwatch.observer/filing/0001387131-22-002576.md","text":"https://secwatch.observer/filing/0001387131-22-002576.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/0001387131-22-002576-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/awh-8k_022322.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T03:58:31.278620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22ce8ded6c","claim":"Valerie B. Palmieri was appointed as Executive Chairperson at Aspira Women's Health Inc..","evidence_excerpt":"On February 23, 2022, the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Valerie B. Palmieri as its Executive Chairperson, effective as of March 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/0001387131-22-002576-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairperson"}],"fact_type":"executive_change"},{"claim_id":"8e940046fa","claim":"Nicole Sandford was appointed as President and Chief Executive Officer at Aspira Women's Health Inc..","evidence_excerpt":"On February 23, 2022, the Board appointed Nicole Sandford, a current director on the Board, as the Company’s President and Chief Executive Officer, effective as of March 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000138713122002576/0001387131-22-002576-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}